Tom 12, Nr 4 (2020)
Artykuł przeglądowy
Opublikowany online: 2021-01-31
Wyświetlenia strony
966
Wyświetlenia/pobrania artykułu
154
Rak trzustki ― żywieniowe i metaboliczne następstwa choroby i jej leczenia
Gastroenterologia Kliniczna 2020;12(4):138-145.
Streszczenie
Rak trzustki jest nowotworem złośliwym o agresywnym przebiegu i ciągle niskim, nie przekraczającym 9% odsetku wyleczeń. W Polsce choruje na niego ponad 3200 osób rocznie, a podstawą leczenia pozostają rozległe resekcje regionalne zmieniające trwale zarówno anatomię, jak i fizjologie przewodu pokarmowego. Zarówno sam nowotwór, jak i jego leczenie wiążą się z zaburzeniami o charakterze matabolicznym oraz żywieniowym; nasilonym niedożywieniem, cukrzycą typu 3c oraz zewnatrzwydzielniczą niewydolnością trzustki. W pracy omówiono ryzyko występowania powikłań żywieniowych, metody ich diagnozowania oraz zalecenia dietetyczne.
Słowa kluczowe: rak trzustkizewnątrzwydzielnicza niewydolność trzustkiniedożywieniecukrzyca trzustkowa
Referencje
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424.
- Nowotwory Złośliwe w Polsce w 2015 roku. http://onkologia.org.pl/wp-content/uploads/Nowotwory_2015.pdf.
- Mueller TC, Burmeister MA, Bachmann J, et al. Cachexia and pancreatic cancer: are there treatment options? World J Gastroenterol. 2014; 20(28): 9361–9373.
- Pezzilli R, Caccialanza R, Capurso G, et al. Pancreatic enzyme replacement therapy in pancreatic cancer. Cancers (Basel). 2020; 12(2).
- Bye A, Jordhøy MS, Skjegstad G, et al. Symptoms in advanced pancreatic cancer are of importance for energy intake. Support Care Cancer. 2013; 21(1): 219–227.
- Ferrucci LM, Bell D, Thornton J, et al. Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer. 2011; 19(11): 1729–1734.
- Di Sebastiano KM, Yang L, Zbuk K, et al. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr. 2013; 109(2): 302–312.
- Dalal S, Hui D, Bidaut L, et al. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage. 2012; 44(2): 181–191.
- Bachmann J, Heiligensetzer M, Krakowski-Roosen H, et al. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 2008; 12(7): 1193–1201.
- Pausch T, Hartwig W, Hinz U, et al. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery. 2012; 152(3 Suppl 1): S81–S88.
- Tashiro M, Yamada S, Sonohara F, et al. Clinical impact of neoadjuvant therapy on nutritional status in pancreatic cancer. Ann Surg Oncol. 2018; 25(11): 3365–3371.
- Roeyen G, Jansen M, Chapelle T, et al. Diabetes mellitus and pre-diabetes are frequently undiagnosed and underreported in patients referred for pancreatic surgery. A prospective observational study. Pancreatology. 2016; 16(4): 671–676.
- Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology. 2008; 134(4): 981–987.
- Olson SH, Xu Y, Herzog K, et al. Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer. Pancreas. 2016; 45(7): 986–991.
- Hart PA, Baichoo E, Bi Y, et al. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus. Pancreatology. 2015; 15(2): 162–166.
- Hillson R. Pancreatitis, pancreatic cancer, and diabetes. Practical Diabetes. 2016; 33(3): 77–78.
- Layer P, von der Ohe MR, Holst JJ, et al. Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology. 1997; 112(5): 1624–1634.
- Sikkens ECM, Cahen DL, de Wit J, et al. A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor. J Clin Gastroenterol. 2014; 48(5): e43–e46.
- Hackert T, Schütte K, Malfertheiner P. The pancreas: causes for malabsorption. Viszeralmedizin. 2014; 30(3): 190–197.
- Olsson M, Herrington MK, Reidelberger RD, et al. Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP. Scand J Gastroenterol. 2012; 47(2): 191–196.
- Tahergorabi Z, Khazaei M, Moodi M, et al. From obesity to cancer: a review on proposed mechanisms. Cell Biochem Funct. 2016; 34(8): 533–545.
- Park JW, Jang JY, Kim EJ, et al. Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg. 2013; 100(8): 1064–1070.
- Miyamoto R, Inagaki Y, Ikeda N, et al. Three-dimensional remnant pancreatic volume ratio indicates postoperative pancreatic exocrine insufficiency in pancreatic cancer patients after distal pancreatectomy. Pancreatology. 2020; 20(5): 867–874.
- Kim H, Yoon YS, Han Y, et al. Effects of pancreatic enzyme replacement therapy on body weight and nutritional assessments after pancreatoduodenectomy in a randomized trial. Clin Gastroenterol Hepatol. 2020; 18(4): 926–934.e4.
- Hackert T, Schütte K, Malfertheiner P. The pancreas: causes for malabsorption. Viszeralmedizin. 2014; 30(3): 190–197.
- Karagianni VTh, Papalois AE, Triantafillidis JK. Nutritional status and nutritional support before and after pancreatectomy for pancreatic cancer and chronic pancreatitis. Indian J Surg Oncol. 2012; 3(4): 348–359.
- Imamura N, Chijiiwa K, Ohuchida J, et al. Prospective randomized clinical trial of a change in gastric emptying and nutritional status after a pylorus-preserving pancreaticoduodenectomy: comparison between an antecolic and a vertical retrocolic duodenojejunostomy. HPB (Oxford). 2014; 16(4): 384–394.
- Powell-Brett S, de Liguori Carino N, Roberts K. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer. Eur J Surg Oncol. 2020 [Epub ahead of print].
- Beger HG, Mayer B, Poch B. Resection of the duodenum causes long-term endocrine and exocrine dysfunction after Whipple procedure for benign tumors - Results of a systematic review and meta-analysis. HPB (Oxford). 2020; 22(6): 809–820.
- Bartel MJ, Asbun H, Stauffer J, et al. Pancreatic exocrine insufficiency in pancreatic cancer: A review of the literature. Dig Liver Dis. 2015; 47(12): 1013–1020.
- Sabater L, Calvete J, Aparisi L, et al. [Pancreatic and periampullary tumors: morbidity, mortality, functional results and long-term survival]. Cir Esp. 2009; 86(3): 159–166.
- Lohr KW, Vriens MR, Gerritsen A. Unintentional weight loss is the most important indicator of malnutrition among surgical cancer patients. Neth J Med. 2012; 70: 365–366.
- Hendifar A, Osipov A, Khanuja J, et al. Influence of body mass index and albumin on perioperative morbidity and clinical outcomes in resected pancreatic adenocarcinoma. PLoS One. 2016; 11(3): e0152172.
- van der Gaag NA, Rauws EAJ, van Eijck CHJ, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010; 362(2): 129–137.
- Armstrong T, Strommer L, Ruiz-Jasbon F, et al. Pancreaticoduodenectomy for Peri-Ampullary Neoplasia Leads to Specific Micronutrient Deficiencies. Pancreatology. 2007; 7(1): 37–44.
- Yu HH, Yang TM, Shan YS, et al. Zinc deficiency in patients undergoing pancreatoduodenectomy for periampullary tumors is associated with pancreatic exocrine insufficiency. World J Surg. 2011; 35: 2110–2117.
- Kang JS, Jang JY, Kang MJ, et al. Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors. World J Surg. 2016; 40(2): 440–446.
- Shirakawa S, Matsumoto I, Toyama H, et al. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012; 16(12): 2212–2219.
- Ferrara MJ, Lohse C, Kudva YC, et al. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013; 15(3): 170–174.
- Shirakawa S, Matsumoto I, Toyama H, et al. Pancreatic volumetric assessment as a predictor of new-onset diabetes following distal pancreatectomy. J Gastrointest Surg. 2012; 16(12): 2212–2219.
- Ferrara MJ, Lohse C, Kudva YC, et al. Immediate post-resection diabetes mellitus after pancreaticoduodenectomy: incidence and risk factors. HPB (Oxford). 2013; 15(3): 170–174.
- Burkhart RA, Gerber SM, Tholey RM, et al. Incidence and severity of pancreatogenic diabetes after pancreatic resection. J Gastrointest Surg. 2015; 19(2): 217–225.
- Wu JM, Ho TW, Kuo TC, et al. Glycemic change after pancreaticoduodenectomy: a population-based study. Medicine (Baltimore). 2015; 94(27): e1109.
- Keck T, Hopt UT. Totale Pankreatektomie: Renaissance eines Operations verfahrens. Der Chirurg. 2008; 79(12): 1134–1140.
- Maker AV, Sheikh R, Bhagia V, et al. Diabetes Control and Complications Trial (DCCT) Research Group. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg. 2017; 402(6): 873–883.
- Kłęk S, Jankowski M, Kruszewski W, et al. Standardy leczenia żywieniowego w onkologii. Nowotwory. Journal of Oncology. 2015; 65(4): 320–337.
- van Berge Henegouwen MI, Moojen TM, van Gulik TM, et al. Postoperative weight gain after standard Whipple's procedure versus pylorus-preserving pancreatoduodenectomy: the influence of tumour status. Br J Surg. 1998; 85(7): 922–926.
- Sobotka L, et al. Podstawy żywienia klinicznego. Edycja Czwarta. Scientifica. 2013; 8(9): 529–547.
- Ciborowska H, Rudnicka A. Dietetyka. Żywienie Zdrowego i chorego człowieka. PZWL 2010.
- Lisowska KA, Bryl E. Rola witaminy D w rozwoju chorób autoimmunologicznych. Postępy Hig Med Dosw. 2017; 71: 797–810.
- Scheers N. Regulatory effects of Cu, Zn, and Ca on Fe absorption: the intricate play between nutrient transporters. Nutrients. 2013; 5(3): 957–970.
